ArticleJournal of primary care & community health
Regional Differences and Trends Within Texas in HPV Vaccination Among Medicaid-insured Adolescents.
Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe purpose of this study was to compare regional HPV vaccination rates and trends among the Texas Medicaid population of adolescents in 2019 to 2021.
methodsWe constructed 3 annual cross-sectional cohorts from Texas Medicaid data from 2019 to 2021, including a total of 1 531 301 individuals contributing 2 757 577 person-years of adolescents aged 9-18 for this analysis. The primary outcome was an observed HPV vaccine dose during the study period. We conducted multivariable logistic regression to estimate the odds of HPV vaccination based on region and the socio-demographic predictor variables.
resultsOverall, the HPV vaccination incidence rate was 13.1% for Medicaid adolescent clients in Texas. The 2020 and 2021 cohorts were significantly less likely to be vaccinated for HPV than the 2019 cohort. Regional variation was detected for adolescents. Significant differences were observed in both age cohorts by sex, race/ethnicity, urbanicity, and cohort year.
conclusionDeclines in HPV vaccination after the COVID-19 pandemic among Texas Medicaid-insured adolescents are of urgent concern if HPV-related cancers are to be prevented. Furthermore, regional differences are apparent throughout Texas, which may contribute to an unequal burden of future disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.